دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: an emerging therapeutic target
Filippo Crea
doi : 10.1093/eurheartj/ehac553
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3815–3818
European Heart Journal paper on COVID-19 scoops top award for London-based researcherÂ
Judith Ozkan
doi : 10.1093/eurheartj/ehac454
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3819–3820
EHJ editorial board: changes in clinical trials team
Judith Ozkan
doi : 10.1093/eurheartj/ehac449
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Page 3821
Which mechanical circulatory support device in acute myocardial infarction complicated by cardiogenic shock?Â
Rocco Vergallo, Daniela Pedicino
doi : 10.1093/eurheartj/ehac475
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3822–3823,
Control of residual dyslipidaemic riskÂ
Eugene Braunwald
doi : 10.1093/eurheartj/ehac359
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3824–3825
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)
Sigrun Halvorsen, Julinda Mehilli, Salvatore Cassese, Trygve S Hall, Magdy Abdelhamid, Emanuele Barbato, Stefan De Hert, Ingrid de Laval, Tobias Geisler, Lynne Hinterbuchner, Borja Ibanez, Radosław Lenarczyk, Ulrich R Mansmann, Paul McGreavy, Christian Mueller, Claudio Muneretto, Alexander Niessner, Tatjana S Potpara, Arsen Ristić, L Elif Sade, Henrik Schirmer, Stefanie Schüpke, Henrik Sillesen, Helge Skulstad, Lucia Torracca, Oktay Tutarel, Peter Van Der Meer, Wojtek Wojakowski, Kai Zacharowski, ESC Scientific Document Group
doi : 10.1093/eurheartj/ehac270
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3826–3924
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementÂ
Florian Kronenberg, Samia Mora, Erik S G Stroes, Brian A Ference, Benoit J Arsenault, Lars Berglund, Marc R Dweck, Marlys Koschinsky, Gilles Lambert, François Mach, Catherine J McNeal, Patrick M Moriarty, Pradeep Natarajan, Børge G Nordestgaard, Klaus G Parhofer, Salim S Virani, Arnold von Eckardstein, Gerald F Watts, Jane K Stock, Kausik K Ray, Lale S Tokgözoğlu, Alberico L Catapano
doi : 10.1093/eurheartj/ehac361
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3925–3946
This 2022 European Atherosclerosis Society lipoprotein(a) [Lp(a)] consensus statement updates evidence for the role of Lp(a) in atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis, provides clinical guidance for testing and treating elevated Lp(a) levels, and considers its inclusion in global risk estimation.
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trialÂ
Jean Claude Tardif, Marc A Pfeffer, Simon Kouz, Wolfgang Koenig, Aldo P Maggioni, John J V McMurray, Vincent Mooser, David D Waters, Jean C Grégoire, Philippe L L’Allier, J Wouter Jukema, Harvey D. White, Therese Heinonen, Donald M Black, Fouzia Laghrissi-Thode, Sylvie Levesque, Marie Claude Guertin, Marie Pierre Dubé, for the dal-GenE Investigators
doi : 10.1093/eurheartj/ehac374
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3947–3956
In a retrospective analysis of dal-Outcomes, the effect of dalcetrapib on cardiovascular events was influenced by an adenylate cyclase type 9 (ADCY9) gene polymorphism. The dal-GenE study was conducted to test this pharmacogenetic hypothesis.
Pharmacogenetics-guided CETP inhibition: an open question?Â
Anne Tybjærg-Hansen, Liv Tybjærg Nordestgaard, Mette Christoffersen
doi : 10.1093/eurheartj/ehac398
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3957–3959
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcificationÂ
Yannick Kaiser, Janine E van der Toorn, Sunny S Singh, Kang H Zheng, Maryam Kavousi, Eric J G Sijbrands, Erik S G Stroes, Meike W Vernooij, Yolanda B de Rijke, S Matthijs Boekholdt, Daniel Bos
doi : 10.1093/eurheartj/ehac377
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3960–3967
Lipoprotein(a) [Lp(a)] is a potential causal factor in the pathogenesis of aortic valve disease. However, the relationship of Lp(a) with new onset and progression of aortic valve calcium (AVC) has not been studied. The purpose of the study was to assess whether high serum levels of Lp(a) are associated with AVC incidence and progression.
Lipoprotein(a) and aortic valve stenosis: work in progressÂ
Florian Kronenberg
doi : 10.1093/eurheartj/ehac436
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3968–3970
Heart–brain interactions in cardiac and brain diseases: why sex matters
Alexia Rossi, Nidaa Mikail, Susan Bengs, Ahmed Haider, Valerie Treyer, Ronny Ralf Buechel, Susanne Wegener, Katrin Rauen, Ahmed Tawakol, C Noel Bairey Merz, Vera Regitz-Zagrosek, Catherine Gebhard
doi : 10.1093/eurheartj/ehac061
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Pages 3971–3980
Cardiovascular disease and brain disorders, such as depression and cognitive dysfunction, are highly prevalent conditions and are among the leading causes limiting patient’s quality of life.
Atypical left anterior descending coronary artery damage after pacemaker lead insertionÂ
Simon Fitouchi, Eric Quiring, Babe Bakouboula
doi : 10.1093/eurheartj/ehac423
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Page 3981
Optical coherence tomography imaging evidence of thrombus inside the tunnel of Patent Foramen Ovale
Wei Ren, Haojia Huang, Haibo Hu
doi : 10.1093/eurheartj/ehac465
European Heart Journal, Volume 43, Issue 39, 14 October 2022, Page 3982
